Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05604781 · ClinicalTrials.gov registry record
Symfony/Synergy IOL Combination Outcomes
A clinical trial, sponsored by Center For Sight.
- Completed
- Registry status
- 41
- Enrollment target
NCT05604781 is a clinical trial that has completed, run by Center For Sight. The registered enrollment target is 41 participants.
The verdict
NCT05604781 has completed, sponsored by Center For Sight.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
Current visual outcomes expectations of cataract patients are similar to those of refractive surgery patients. Their desire is to be spectacle independent for far, intermediate and near vision activities. Some may have already enjoyed freedom from glasses and would like to continue after the cataracts are removed. Different options are available. These options include: mono-vision and presbyopia correcting intraocular lenses (IOL). Presbyopia correcting IOLs include accommodative, multifocals and extended depth of focus (EDOF) IOLs. In a previous study that evaluated the visual outcomes of an EDOF IOL when combined with a multifocal IOL with a +3.25 D add in patients with or without astigmatism undergoing routine cataract surgery showed good outcomes with high patient satisfaction and less dependance on glasses for intermediate and near activities. As technology evolves, new lens models are available in the market. The purpose of this study is to evaluate the latest EDOF and a hybrid multifocal lenses when combined.
Interventions
- DEVICE Symfony & Synergy IOL combination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2022-10-17 |
| Est. Completion | 2023-05-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05604781
The ClinicalTrials.gov registry entry for NCT05604781 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Center For Sight, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Symfony & Synergy IOL combination is the first listed.
NCT05604781 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05604781 about?
NCT05604781 is a clinical study titled "Symfony/Synergy IOL Combination Outcomes". Current visual outcomes expectations of cataract patients are similar to those of refractive surgery patients. Their desire is to be spectacle independent for far, intermediate and near vision activities. Some may have already enjoyed freedom from glasses and would like to continue after the catarac...
What is the current status of trial NCT05604781?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2022-10-17. Estimated completion is 2023-05-16.
What interventions are being tested in trial NCT05604781?
The interventions under investigation include: Symfony & Synergy IOL combination (DEVICE).
Who is sponsoring clinical trial NCT05604781?
This trial is sponsored by Center For Sight, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.